EULAV Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

EULAV Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,600	Closed	-$6.51M	–	187
2023 Q1	$6.51M	Hold	13,600	–	–	0.26%	98
2022 Q4	$5.72M	Hold	13,600	–	–	0.25%	101
2022 Q3	$5.67M	Hold	13,600	–	–	0.25%	102
2022 Q2	$6.73M	Hold	13,600	–	–	0.28%	100
2022 Q1	$7.66M	Sell	13,600 -5	-0%	-$2.82K	0.23%	110
2021 Q4	$10.3M	Sell	13,605 -2	-0%	-$1.51K	0.26%	108
2021 Q3	$10.2M	Sell	13,607 -1	-0%	-$746	0.27%	109
2021 Q2	$8.77M	Sell	13,608 -2	-0%	-$1.29K	0.23%	110
2021 Q1	$7.77M	Sell	13,610 -9	-0.1%	-$5.14K	0.21%	118
2020 Q4	$7.94M	Buy	13,619 +19	+0.1%	+$11.1K	0.21%	125
2020 Q3	$7.01M	Sell	13,600 -6	-0%	-$3.09K	0.21%	117
2020 Q2	$6.14M	Sell	13,606 -2	-0%	-$903	0.2%	122
2020 Q1	$4.77M	Buy	13,608 +8	+0.1%	+$2.8K	0.19%	127
2019 Q4	$5.03M	Hold	13,600	–	–	0.17%	138
2019 Q3	$4.53M	Buy	13,600 +1,700	+14%	+$566K	0.17%	141
2019 Q2	$3.72M	Buy	11,900 +5,500	+86%	+$1.72M	0.14%	162
2019 Q1	$1.97M	Buy	+6,400	New	+$1.97M	0.08%	208
2018 Q3	–	Sell	-4,400	Closed	-$1.27M	–	289
2018 Q2	$1.27M	Hold	4,400	–	–	0.06%	219
2018 Q1	$1.1M	Hold	4,400	–	–	0.05%	223
2017 Q4	$1.05M	Hold	4,400	–	–	0.05%	230
2017 Q3	$978K	Hold	4,400	–	–	0.05%	241
2017 Q2	$996K	Hold	4,400	–	–	0.05%	242
2017 Q1	$877K	Hold	4,400	–	–	0.04%	251
2016 Q4	$802K	Hold	4,400	–	–	0.04%	249
2016 Q3	$721K	Buy	4,400 +1,600	+57%	+$262K	0.04%	254
2016 Q2	$400K	Hold	2,800	–	–	0.02%	258
2016 Q1	$383K	Hold	2,800	–	–	0.02%	269
2015 Q4	$388K	Hold	2,800	–	–	0.02%	280
2015 Q3	$376K	Hold	2,800	–	–	0.02%	288
2015 Q2	$422K	Buy	2,800 +1,000	+56%	+$151K	0.02%	300
2015 Q1	$243K	Buy	+1,800	New	+$243K	0.01%	321
2014 Q3	–	Sell	-5,600	Closed	-$670K	–	352
2014 Q2	$670K	Sell	5,600 -2,400	-30%	-$287K	0.04%	343
2014 Q1	$1.03M	Hold	8,000	–	–	0.06%	321
2013 Q4	$989K	Hold	8,000	–	–	0.05%	329
2013 Q3	$940K	Hold	8,000	–	–	0.05%	337
2013 Q2	$898K	Buy	+8,000	New	+$898K	0.05%	342